As drug developers rely increasingly on artificial intelligence to assist with the discovery, testing and manufacture of new medicines, researchers at the Defense Health Agency Research and Development-Medical Research and Development Command are learning how to apply the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines that protect our Warfighters and enable them to maintain operational effectiveness even in chemically and biologically contaminated environments.